US EditionPublished • loading... • Updated
Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
Rakuten Medical provides academic researchers broader access to IR700 dye, a clinically validated, low-toxicity component in Akalux, to foster innovation in medical therapies.
- Rakuten Medical announced broader academic access to its IR700 dye, the component used in the approved medicine Akalux, for academic researchers and institutions.
- To accelerate discovery, Rakuten Medical is expanding access by broadening availability of IR700 to academics and institutions, aiming to drive open innovation and new medical discoveries.
- The IR700 dye's hydrophilicity and low toxicity make it research-friendly, supporting diverse therapeutic modalities, Rakuten Medical said.
- Broader access positions academics to test a clinically validated agent, which could speed discovery in academic labs and influence future drug development with new therapeutic modalities.
- Because IR700 is used in Akalux, the move carries prominence since the dye is part of an approved therapy, broadening research opportunities.
Insights by Ground AI
18 Articles
18 Articles
The Union Democrat+17 Reposted by 17 other sources
Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
Rakuten Medical's light-activatable IR700 dye is a clinically validated component used in the approved medicine Akalux™With hydrophilicity and low toxicity1, IR700 dye is adaptable to diverse therapeutic modalitiesBroader academic access to IR700 dye will accelerate open innovation and drive new…
Coverage Details
Total News Sources18
Leaning Left1Leaning Right0Center12Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
